BioCardia News

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $4 Price Target

BenzingaNov 14, 2023 11:22 ET

BioCardia Analyst Ratings

BenzingaNov 14, 2023 11:20 ET

Analysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and Femasys (FEMY)

TipRanksNov 14, 2023 10:40 ET

BioCardia's Strategic Clinical Advancements and Potential Growth Opportunities Prompt Buy Rating

TipRanksNov 9, 2023 06:51 ET

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $4 Price Target

BenzingaOct 11, 2023 12:35 ET

BioCardia Analyst Ratings

BenzingaOct 11, 2023 12:33 ET

HC Wainwright & Co. Maintains Buy on BioCardia, Lowers Price Target to $4

BenzingaSep 6, 2023 10:50 ET

BioCardia Analyst Ratings

BenzingaSep 6, 2023 10:49 ET

H.C. Wainwright Remains a Buy on BioCardia (BCDA)

TipRanksSep 6, 2023 10:35 ET

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $9 Price Target

BenzingaAug 10, 2023 06:28 ET

BioCardia Analyst Ratings

BenzingaAug 10, 2023 06:27 ET

H.C. Wainwright Sticks to Their Buy Rating for BioCardia (BCDA)

TipRanksAug 10, 2023 06:15 ET

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $9 Price Target

BenzingaJul 24, 2023 12:43 ET

BioCardia Analyst Ratings

BenzingaJul 24, 2023 12:42 ET

H.C. Wainwright Keeps Their Buy Rating on BioCardia (BCDA)

TipRanksJul 24, 2023 10:55 ET

H.C. Wainwright Remains a Buy on BioCardia (BCDA)

TipRanksJul 5, 2023 08:55 ET

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $9 Price Target

BenzingaJun 21, 2023 06:28 ET

HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $9 Price Target

BenzingaMay 11, 2023 06:33 ET

H.C. Wainwright Sticks to Their Buy Rating for BioCardia (BCDA)

TipRanksMay 11, 2023 06:25 ET

BioCardia (BCDA) Receives a Buy From H.C. Wainwright

TipRanksMar 30, 2023 06:33 ET